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Available online 29 September 2016Introduction: Deep brain stimulation (DBS) nowadays is a well-established treatment of motor symptoms in
Parkinson's disease. The subthalamic nucleus (STN) is a common target for DBS, because motor improvements
have been shown to be superior to best medical therapy, if DBS electrodes have been appropriately positioned.
DBS target identiﬁcation can be assisted by MRI beyond structural imaging by spatially resolved measurement
of T2-relaxation times (T2r).
Aim:We pose the question, whether T2r of the STN is linked to the severity of the disease and whether outcome
of DBSmay be correlated to an asymmetricmanifestation of the disease. Further,we investigated if abnormal T2r
in the STN may be predictive for outcome of DBS.
Methods: Twelve patients underwent preoperative MR imaging including a multi echo relaxometry sequence
(3 Tesla, Siemens Medical Systems, Erlangen, Germany) ahead of DBS. T2r were determined for STN, substantia
nigra (SN), red nucleus (RN) and centrum semiovale (CSO). Uniﬁed Parkinson's disease Rating Scale (UPDRS)
scores were tested before and after DBS. Patients' T2r and deduced values representing left-right asymmetry of
measurements were correlated with UPDRS scores and measures for outcome of DBS. Furthermore, patients'
T2r were compared with T2r measurements in 12 healthy controls (HC).
Results: Patients' T2r for SN (mean 45.4 ms ± 4.4 ms) and STN (mean 56.4 ms ± 3.8 ms) were signiﬁcantly
shorter than T2r in HCs for SN (mean 60.7 ± 4.6) and STN (mean 66.1 ms ± 4.0 ms). While no mean T2r asym-
metrywas found in the SN, patients' mean T2r for STN showed aweakened left-right correlation (Pearson corre-
lation coefﬁcient 0.19 versus 0.72 in HC) indicating asymmetric degeneration. T2r asymmetry was not linked to
the more severely affected hemisphere.
The respective lower T2rwithin the left or right target regionwas signiﬁcantly correlated to the outcome in terms
of UPDRS III improvement in “off” state (Pearson correlation 0.82 corresponding to p≪ 0.01). Patientswith T2r of
STN lower than 50 ms showed no response to DBS in the UPDRS.
The maximum T2r for SN correlated to the improvement between UPDRS “off” minus and “on” (Dopamine re-
sponse) but failed to predict DBS outcome.
Conclusions: The lower boundaries of T2r in the STN predict motor outcome in DBS. T2r asymmetry in the STN is
not associated with increased clinical symptoms, but with response to therapy. Thus, patients with very low T2r
may be inappropriate candidates for DBS.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Parkinson's disease
Deep brain stimulation
Subthalamic nucleus
Basal ganglia
T2 relaxometry1. Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disease
affecting the human nervous system on a multisystem level. The motoriagnostic and Interventional
iversity of Bern, Freiburgstr. 4,
Weitzel).
. This is an open access article undersymptoms are considered to derive from a loss of dopaminergic projec-
tion neurons in the substantia nigra (SN) and accumulation of iron de-
posits in the SN. DBS is nowadays a well established therapy not only
for advanced PD with ﬂuctuating motor symptoms and dyskinesia
(Deuschl et al., 2006), but has been proven to be superior to medical
therapy at early stages of PD ahead of disabling motor complications
(Schuepbach et al., 2013a). In younger patients the subthalamic nucleus
(STN) is the target of choice to improve motor symptoms. Most often
STN is targeted bilaterally (Moro et al., 1999). The globus pallidusthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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responsive symptoms and motor ﬂuctuations (Benabid et al., 2009;
Follett et al., 2010; Odekerken et al., 2013; Okun et al., 2009; Weaver
et al., 2009). Unilateral versus bilateral approaches to DBS both emerged
to be efﬁcacious to improve motor dysfunction (Shemisa et al., 2011),
yet it remains an open question as how to appropriately determine uni-
lateral approaches for a subset of patients. Patients with marked asym-
metry of motor symptomsmay beneﬁt from unilateral DBS, if the target
nucleus can be properly identiﬁed.
The rationale for MRI in PD is traditionally anchored in the exclusion
of atypical Parkinson syndromes.
Current diagnosticmethods for Parkinsonism include in some extent
18F-ﬂuorodeoxyglucose Positron Emission Tomography (FDG-PET) as
well as dopaminergic receptor imaging by PET or single photon emis-
sion CT (SPECT). 18F-ﬂuorodopa PET, 11C-dihydrotetrabenazine PET,
FDG-PET and 123I-beta-carbomethoxy-3beta-(4-iodophenyl)tropane
(DAT)-SPECT have been used to detect the loss of dopaminergic presyn-
aptic terminals in the putamen originating from the SN pars compacta
in PD patients (Ravina et al., 2005). Neuromelanin imaging at 3TMRI of-
fers another aspect of changes within PD (Castellanos et al., 2015; Keita
et al., 2016). Furthermore transcranial ultrasonographic imaging of the
midbrain is discussed as a possible method for early assessment of de-
generation of SN. (Bouwmans et al., 2013; Li et al., 2016).
Methods to assist diagnosis of PD with MRI are now evolving,
encompassing quantitative iron assessment and neuromelanin sensi-
tive MRI (Baudrexel et al., 2010; Ohtsuka et al., 2014). In research set-
ting, arterial spin labeling and functional MRI using connectivity
analysis have found profound differences between PD and HC (Detre
et al., 2009; Robinson et al., 2009). To our knowledge, no previous MRI
study aimed at a prediction of DBS outcome, except of a seminal study
(Watanabe et al., 2012) that correlated T2r in STN to neurophysiological
parameters, disease duration and laterality.
The degeneration of SN in PD involves iron accumulation, which can
be assessed by T2 and T2* relaxometry. These values, correlated with
micro structural characteristics of tissues, provide absolute, tissue spe-
ciﬁc, ﬁeld strength and machine independent T2 values and are highly
sensitive to e.g. iron content (Carneiro et al., 2006). In this study, we in-
vestigatedwhether a decrease of T2 relaxation times in the subthalamic
nucleus (STN) can be used as surrogate marker for target selection in
DBS. Our assumption was that i) an asymmetric clinical presentation
is reﬂected by asymmetric degeneration within the basal ganglia
loops, which could possibly be detected by T2r changes compared to
HC and that ii) an asymmetric degeneration may affect the motor out-
come of DBS. Patients with a high asymmetric index in motor function
have proﬁted of unilateral DBS in means of improvement of ipsi- and
contralateral UPDRS, so that only few patients required a second DBS
(Houtan et al., 2010). The T2r values could predict the degree of degen-
eration requiring bilateral or only unilateral DBS. Furthermore a severe
degeneration within the basal ganglia loop, as seen by T2r values
could predict a poor response to DBS and affect future patient eligibility.
The neuroradiological assumption is to see, if the iron content as
seen by T2r values asymmetrically or symmetrically correlates with
PD symptoms and/or DBS outcome.2. Subjects and methods
Fourteen DBS patients (9 men, 5 women) with the standard neuro-
logical preoperative work-up of determining levodopa-responsive PD
with motor complications and without contraindications underwent
preoperative imaging including T2 relaxometry. Inclusion criteria to
this study were DBS implantation, completed imaging protocol and
pre- and post-operative UPDRS assessment. Two male subjects had to
be excluded because of motion artifacts in the imaging. Mean age of
evaluated patients (7 men, 5 women) was 63,25 years (range 44–80,
median 62.5, SD 10.89) and all patients were right handed.Twelve right handed controls (HC healthy controls) were examined
(6 men, 6 women, age range 20–41, age average 28.5, age median 27,
age SD 6.5). Exclusion criteria were, according to individual medical
history, neurological diseases other than PD, drug abuse or neurologic
disorders in 1st or 2nd line relatives.
The UPDRS scores I, II and III were assessed by a specialized
paramedic of the Movement Disorder Center of our Institution's
Neurological Department. UPDRS I (“cognitive”) was determined dur-
ing “on”-state while UPDRS II (“daily living”) and UPDRS III (“motor”)
were determined in “on” as well as in “off” state. In addition the
UPDRS III scores were determined separately for left and right sided
symptoms yielding the according left and right UPDRS III subscores.
All scores were determined 3 to 6 weeks preoperatively as well as 12
to 26 weeks postoperatively. DBS outcome was assessed by analyzing
the differences of respective preoperative and postoperative UPDRS
scores.
Patients and controls were examined at the 3 Tesla scanners
(Siemens Magnetom Trio and Siemens Magnetom Verio; Siemens
Medical Solutions, Erlangen, Germany) of our institution. T2r MRI data
were acquired with identical multi-contrast spin echo (SE) sequences
on both of the similar scanners. Themulti-echo, fast spin echo sequence
used the following parameters: 28 coronal contiguous 2mm slices, FOV
220 mm, acquisition matrix 128 × 128, TR = 2000 ms and multiple TE
ranging from 12 ms to 96 ms in steps of 12 ms. Acquisition time for
the T2 datawas 6.16min. The total scan time for the entire imaging pro-
tocol was 38 min.
STN (left and right), SN (left and right) and for comparison RN (left
and right) and CSO (right only) were chosen as regions of interest
(ROI). The free hand ROIs were placed manually using an image at
TE = 72 ms where the STN showed best contrast in a coronal plane
on the T2 weighted image. The ROIs were chosen to cover the centers
of the nuclei with the resulting signal being the average of the intensity
values covered by the chosen ROIs. The ROI was positioned in the mid-
dle of the selected structure to avoid miscalculation due to partial vol-
ume of the surrounding tissue. Additional ROIs were positioned into
the SN. For reference values ROIs were placed into NR bilaterally and
into right CSO. Schaltenbrand and Wahren's Anatomic Atlas (1977)
and Salamon's Neuroanatomy and Neurovasculature Web-Atlas
Resource (2013) were used as the anatomic reference for manual ROI
placements.
The absolute T2r were calculated from the T2 signal decay from the
multi echo sequence. UPDRS III, i.e. the motor part of the UPDRS, was
chosen for the clinical correlation as the standard clinical assessment
scale for the severity of disease. Measured signal intensities for each
TE were averaged for every selected region of interest (ROI). Signal
decay time (T2) was calculated for each selected region of interest
(ROI) as decay constant according to a robust least-squares ﬁt of a
mono exponential decay according to Formula 1:
Signal TEð Þ ¼ const  exp − TE
T2
 
ð1Þ
The ﬁtting algorithm for each ROI was applied to the 7 measure-
ments from TE = 24 ms to TE = 96 ms. Measurements at TE = 12 ms
were omitted to avoid non-exponential components of the signal at
very short TE (Jones, 2003). Furthermore the formula assumes the con-
stant including the factor ð1− expð− TRT1ÞÞ being independent from TE.
According to the 7 ROIs the calculations resulted in a set of 7 T2 values
for every patient and control. As the tissue speciﬁc T2r values are calcu-
lated from the decay curves regardless of absolute signal intensities the
measurements are independent of the actual 3T scanner used.
For statistical workup, themeasured T2r values for left side and right
side were supplemented by the T2r mean, max and min values as well
as the difference between left and right T2r values (all values in ms).
Also the UPDRS scores were supplemented in a similar manner by dif-
ference scores (difference pre-operative minus post-operative,
Table 2
UPDRS differences preoperative minus postoperative.
Mean Std. Dev.
Δ_UPDRS_I −0.42 1.31Δ_UPDRS_II_off 3.83 5.15Δ_UPDRS_II_on 2.75 3.98Δ_UPDRS_III_off 12.25 14.50Δ_UPDRS_III_on 2.00 8.91
Table 3
Left and right sidemean and difference T2r inms for controls and patients. STN_dif means
T2 value in left STN minus T2r in the right STN NR_dif and SN_dif were derived
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resulting sets of T2r values and UPDRS scores were determined and an-
alyzed for patients and HC. Furthermore for patients and HC possible
correlations of T2r values with sex or age were tested.
3. Results
3.1. UPDRS pre- and post-operative
Patients averaged preoperative and postoperative total UPDRS I, II
and III scores in “off”-state and in “on”-state are shown in Table 1. The
designation “on” and “off” refers to dopaminergic medication. The DBS
itself, after implantation, was always switched on.
Difference scores (Δ_UPDRS) were calculated as respective differ-
ence of preoperative UPDRS scores minus postoperative UPDRS scores
and were interpreted as outcome. Positive Δ_UPDRS scores represent
positive outcome of DBS.
The averaged preoperative UPDRS scores reﬂected the inclusion
criteria for DBS and thus showed the comparatively smallest standard
deviation. The positive averagedΔ_UPDRS scores represented the over-
all positive outcome of DBS. The higher standard deviation of the post-
operative UPDRS scores and in particular the high standard deviation
of theΔ_UPDRS scores with relative standard deviations above 100% in-
dicated a highly variable outcome of DBS.
The differences in pre- and postoperative UPDRS scores (Δ_UPDRS)
according to groups I–III are shown in Table 2. The UPDRS improve-
ments were mostly due to improved motor (UPDRS III) performance
during “off”-state as represented by Δ_UPDRS_III_off. The comparative-
ly high standard deviation again reﬂects the variability in response to
therapy.
3.2. T2 relaxation times in patients and controls
Table 3 compares mean and difference of left and right T2r values of
the ROIs for HC und patients. T2r for NR (mean left and right side)
showed a non signiﬁcant decrease in patients (60.39 ± 4.27 ms) com-
pared to HC (64.82 ± 5.16 ms). T2r for CSO indicated a non signiﬁcant
increase in patients (84.98 ± 3.31 ms) compared to HC (78.67 ±
1.79 ms).
Patients and HC signiﬁcantly differed in measured T2r (mean left
and right side) for STN and SN. Patient's T2r of STN (56.46 ± 3.81 ms)
showed a decrease of almost 3 standard deviations in comparison to
HC (66.10 ± 3.99 ms). Patient's T2r of SN (45.41 ± 4.42 ms) showed
a signiﬁcant decrease of N3 standard deviations in comparison to HC
(60.72 ± 4.65 ms).
The calculated left to right differences of T2r showed an increased
left to right difference as well as an increased variability of left to right
differences of T2r of STN for patients (STN_dif 0.91 ± 6.52 ms) in com-
parison to HC (0.47± 3.51ms) implicating occurrences of unilateral al-
terations as shown in Table 3.
The unilateral UPDRS III scores showed a slight but insigniﬁcant em-
phasis of left sided symptoms. Consequently, despite the signiﬁcant de-
crease of STN T2r in patients, the Pearson correlations of left and right
STN T2r with left and right UPDRS III showed no signiﬁcant relation.
To illustrate differences in T2r values in controls and patients and
asymmetric T2r the measurements are shown as two-dimensionalTable 1
Total UPDRS and differences preoperative minus postoperative in on and off state.
Mean Std. Dev. Relative Std. Dev.
UPDRS_off_pre 51.92 9.84 19.0%
UPDRS_off_post 36.25 15.47 42.7%Δ_UPDRS_off 15.67 19.05 121.6%
UPDRS_on_pre 25.00 7.91 31.6%
UPDRS_on_post 20.67 11.26 54.5%Δ_UPDRS_on 4.33 11.40 263.3%diagrams with the measured T2r in the right hemisphere on the
horizontal axis and the measured T2r in the left hemisphere on the
vertical axis.
Fig. 1 illustrates T2r differences in controls vs. patients for the SN
(left vs. right). For subjects with higher T2r in both groups there was a
slight tendency to show higher T2r on the right side as visualized by
the lines of best ﬁt with a slope below 45°. Nevertheless for both groups
the left and right values were highly correlated (Pearson Correlation
r= 0.76 for controls and r= 0.61 for patients) indicating good parity.
Furthermore, the data showed a signiﬁcant correlation of the differ-
ence in preoperative UPDRS III scores in “off” vs. “on” state with the
minimum right or left SN T2r value (Pearson correlation 0.74), i.e. the
higher the remaining minimal SN T2r value, the higher the effect of do-
paminergicmedication. No signiﬁcant T2r differenceswere detected be-
tween controls and patients in the RN. Left and right T2r were highly
correlated (Pearson Correlation 0.77 for volunteers and 0.61 for pa-
tients) indicating good parity.
Fig. 2 shows T2r of the STN in patients vs. controls. In controls left
and right T2r were highly correlated (Pearson Correlation r = 0.72).
In patients, in contrast, the left to right correlation was almost lost
(Pearson Correlation r = 0.19) indicating predominantly unilateral
alteration of the STN. Five patients had T2r in the range of healthy
controls (N60 ms for STN_right), whereas only one single patient had
T2r values N60 ms in STN_left.
Patients and controls differ in terms of decreased STN T2r (b58 ms)
either uni- or bilaterally.While varying lateralization naturally weakens
any correlation for mean T2r of STN the ﬁgure suggests correlations if at
least one of left or right STN showed decreased T2r i.e. correlationswith
the minimum of left or right T2r.
Neither correlations of T2r and UPDRS to sex or age for patients nor
correlations of T2r to sex or age for HC showed any signiﬁcance.3.3. Correlation of T2 relaxation times with UPDRS and outcome
Fig. 3 shows Δ_UPDRS_III_off vs. STN_min indicating that STN_min
i.e. the minimum T2r value measured for STN right or left is highly cor-
related to the outcome of DBS in terms of UPDRS III improvement in
“off” state. The Pearson correlation of STN_min to Δ_UPDRS_III_off is
r= 0.82 corresponding to a p b 0.01.
Patients with pronounced asymmetry (T2 left STN minus T2 right
STN) revealed the most prominent improvement of the UPDRS III.accordingly.
Controls Patients
Mean Std. Dev. Mean Std. Dev.
STN_mean 66.10 3.99 56.46 3.81
STN_dif 0.47 3.51 0.91 6.52
SN_mean 60.72 4.65 45.41 4.42
SN_dif 2.15 3.54 1.17 4.37
NR_mean 64.82 5.16 60.39 4.27
NR_dif −0.21 3.79 0.50 4.22
CSO 78.67 1.79 84.98 3.31
r=0.76
r=0.61
Fig. 1. Left and right SN T2r in patients and controls.
r=0.82
Fig. 3. Dependency of DBS outcome as determined by Δ_UPDRS_III_off on minimal T2r of
STN.
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conﬁrmed and medical records reexamined. Patients with a negative
UPDRS apparently seemed to deteriorate with rapidly progressive levo-
dopa-resistant axial symptoms. The one patient with considerably neg-
ative outcome developed dementia.
4. Discussion
This study aimed to investigate whether decreases in the T2r in the
STN and SN are predictive for motor outcome in PD. Two points stand
out from our study:
1) T2r changes in the SN and in STN differentiate PD patients from
HC. This ﬁnding conﬁrms previous studies (Martin et al., 2008;
Sian-Hülsmann et al., 2011) and has been conﬁrmed by transcranial so-
nography (Berg, 2009). SeveralMRImethods are on trial for initial diag-
nosing PD (Ohtsuka et al., 2014). T2r is not the only MRI marker for
distinction of PD andHC, e.g. resting state functionalMRI, R2*,mean dif-
fusivity and fractional anisotropy have also been found to haver=0.19
r=0.72
Fig. 2. Left and right STN T2r in patients and controls.signiﬁcant differences within the basal ganglia (Planetta et al., 2014;
Prodoehl et al., 2014; Tir et al., 2014). Our ﬁndings implicate, that T2-
relaxometry of STN and SN should be further evaluated to test if it offers
the potential to differentiate early PD fromHC and secondary Parkinson
syndromes.
2) STN asymmetry and T2r minimum values were associated with
better outcome of DBS in our patients. Lower T2r values may be
reﬂected clinically bymore severemotor impairment and thus a greater
potential for improvementwith DBS. Itmay be implicated that informa-
tion gleaned from preoperative MRI may have a prognostic value and
may be implemented as a potential surrogate marker for the prediction
of successful DBS. Clues from our study may further implicate whether
dissatisfaction with STN DBS in long term management (Farris and
Giroux, 2013) can be predicted based on MRI ﬁndings. Patients with
an unfavorable outcome in our cohort hadworsening of levodopa-resis-
tant axial symptoms, which are not expected to be improved by STN
DBS. T2r values may be an indicator for this development.
While patients tend to show an unilateral decrease of STN T2r the
laterality of symptoms was not reﬂected by the asymmetry of STN T2r.
Lateralized manifestations of motor symptoms are characteristic for id-
iopathic PD (van der Hoorn et al., 2012) which, however, is invariably a
bilateral disorder. During the progression of the disease laterality is usu-
ally preserved to some degree. This has until date not been correlated to
intrinsic unilateral or side dominant changes within the brain on MRI.
The dopaminergic innervation of the striatum is known to reﬂect the
asymmetry of symptoms during onset and progression of PD (Marek
et al., 1996). However, there is evidence to suggest that components
of the basal ganglia loops are functionally connected across hemi-
spheres (de Solages et al., 2010). This supports the observation that
DBS outcome was best when at least one STN had near to normal T2r,
independent of the most affected side of symptoms. Though, in context
of DBS with targeting the basal ganglia, the degree of affection and
laterality may impact clinical outcome (Kingsbury et al., 2010). Patients
may also proﬁtmore of DBS during an earlier stage (Deuschl et al., 2013;
Schuepbach et al., 2013b).
Iron depositions in the nuclei causingmicrostructural changes in tis-
sue are themain factor affecting the T2r. The concept of individually re-
garding left and right minimum and maximum values alongside the
mean T2r values takes lateralization of iron depositions into account.
At which point the increasing iron content in SN or STN correlates to a
clinically manifest PD is under examination. Previous studies indicated
836 T. Lönnfors-Weitzel et al. / NeuroImage: Clinical 12 (2016) 832–837that there is no change in SN iron content in incidental Lewy Body
Disease or in pre-manifest PD, while others have found conﬂicting re-
sults (De Reuck et al., 2014). These ﬁndings may reﬂect different sub-
groups of PD, corresponding to the variation in motor symptoms
exhibited in the disorder (Riederer and Sian-Hülsmann, 2012;
Sian-Hülsmann et al., 2011). Increasing iron content in the SN in pro-
gression of PD has been described (Aquino et al., 2014a). The overall
iron content in the STN did not seem to affect the outcome as
neurodegeneration typically affects the SN but not the STN. Interest-
ingly, T2r in the STN as a structural parameter nevertheless seems to
correlate with clinical ﬁndings. While themean values of STN T2r left
and right provided no additional value, the minimum values of were
correlated to DBS outcome with respect to UPDRS III. Very low
minimum STN T2r predicted negative DBS outcome. More detailed,
patients and controls differed in terms of decreased STN
T2r(b58 ms) either uni- or bilaterally. The clinical data conﬁrmed
the UPDRS improvement in all but three patients, in whom levodo-
pa-resistant axial signs worsened after neurosurgery, as has been re-
ported in earlier studies (Benabid et al., 2009). Alternative Targets
have also been considered, mainly GPi, with no relevant differences
in results of UPDRS improvement (Okun et al., 2009). The latter
may offer an alternative target, if the STN T2 values are very low
and considered predictive for a negative outcome.
The effect of a left dominant hemisphere on DBS has been consid-
ered (Shemisa et al., 2011). The DBS performed on the dominant side
was not proven to have a more beneﬁcial effect than the non-dominant
side.
Our observations on the T2 values of SN are congruent with litera-
ture (Du et al., 2012). Noteworthy is the correlation of SN minimum
T2r values to the levodopa motor response (UPDRS III “off” vs. “on”).
This has not been described before and should be investigated further.
A limitation of this study is the small number of patients affecting
the power to detect differences. However, the correlations we report
are highly signiﬁcant. Our controls were recruited from a distinctly
younger age group, which may result in a bias, even if no correlations
with age were found. A study with age matched HC (Aquino et al.,
2014b) found less pronounced T2r differences between patients and
HC.
Though the initial assumption that the asymmetric iron content
could correlate with asymmetric clinical disease could not be proved,
the data suggest that the outcome of DBS may correlate to the maxi-
mum iron content in either of the STN. Further evaluation is needed to
ensure which patients possibly have to be excluded from DBS.
5. Conclusion
The minimum T2r values of the left or right STNmay be a predictive
factor for motor improvement after STN-DBS.
The lateralization of the T2 values does not correlate with the more
symptomatic side, but seems to indicate that the STN closest to normal
values dictates the outcome. This may represent the imaging correlate
to the hypothesized existence of a dominant STN.
The SN T2r values are reduced in PD patients compared to HC. Low
minimal remaining SN T2r valuesmay indicate a reduced efﬁcacy of do-
paminergic medication. Further studies are needed to evaluate the
prognostic predictive value of very low minimum STN T2 values for
rapid progression of treatment-resistant signs of PD after DBS and
therefore unfavorable outcome.
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